Patient Portal Login
Bill Pay
ILCC Foundation
Patient Resources
Careers
New Patient Referral
Pharmaceutical Representatives
Request/Change an Appointment
Phone:
309.243.3000
or
1.866.662.6564
Pharmacy Phone:
309.243.3404
Home
Why ILCC
Locations
Mission / Values
History
Foundation
Testimonials
Our Staff
Patient Information
News
Smart Care
Laboratory
Pharmacy
Resources
Quality Assurance
Multidisciplinary Clinic
Contact Us
Cancer Treatment
Treatment Overview
Your Visit
List of Cancer Types
What To Ask Your Doctor
Personalized Cancer Care
Pallative Care
Chemotherapy
Radiology
Other Treatments
Laboratory
Cancer FAQ
Blood Disorders
Treatment Overview
Your Visit
List of Blood Disorders
What To Ask Your Doctor
Smart Care
Laboratory
Blood Disorders FAQ
Genetics Clinic
Genetics Overview
Your Visit
Risk Assessment
Appointment Request
Future of Genetics
Genetics FAQ
Clinical Trials
Research Overview
Clinical Trials 101
Current Clinical Trials
Research Leadership Team
Research Resources
Research FAQ
Ask A Researcher
Molecular Testing
Financial Conflict of Interest Disclosures & Policy
Contact
Send Us An Email
Our Locations
Careers
Forms
Submit Your Story
Recent News
FAQ
Current Illinois CancerCare Clinical Trals
Research Overview
Clinical Trials 101
Current Clinical Trials
Molecular Testing
Research Leadership Team
Research FAQ
Ask A Researcher
Research Resources
Articles
Videos
Patient Testimonials
Financial Conflict of Interest Disclosures & Policy
Frontline
A032302
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
Search Again
All Trial Categories
Bladder/Urinary Tract Cancer (3)
Adjuvant (1)
Metastatic (1)
Neoadjuvant (1)
Brain (1)
Glioblastoma Multiforme (GBM) (1)
Breast (7)
Breast Cancer Adjuvant (1)
Non-Trastuzumab Regimens (1)
Breast Cancer Neoadjuvant (4)
Non-Trastuzumab Regimens (3)
Trastuzumab Regimens (1)
Cancer Control/Symptom Management (20)
Colorectal Cancer (4)
Adjuvant (1)
Metastatic (3)
First line (2)
Second Line & Beyond (1)
Cutaneous/ Skin (1)
Esophageal Cancer (1)
Gall Bladder/ Biliary Tract Cancer (1)
Head/Neck Cancer (3)
Leukemia (2)
Acute Myeloid Leukemia (1)
B-Cell Chromic Lymphocytic Leukemia (CLL) / Small Ly (1)
Lung Cancer (20)
Non-Small Cell Lung Cancer (16)
1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence (3)
2nd Line Metastatic, Stage 4 Patients with Progressive Disease (3)
Adjuvant Treatment for Resected NSCLC (5)
Small Cell Lung Cancer (4)
Extensive Stage SCLC (3)
Limited Stage SCLC (1)
Lymphoma (2)
Non-Hodgkin’s Lymphoma (2)
Diffuse Large B-Cell Lymphoma (1)
First Line (1)
Follicular Lymphoma (1)
First Line (1)
MATCH Trial (4)
MDS (1)
Melanoma (2)
Metastatic (1)
Misc. Gynecology (2)
Multiple Myeloma (1)
Primary Induction Therapy (1)
Pancreatic (4)
Adjuvant (1)
Metastatic Disease (2)
Prostate (5)
Castration-resistant (3)
Second Line (3)
Castration-sensitive (2)
Frontline (1)
Second Line (1)
Renal Cell/Kidney Cancer (1)
Adjuvant (1)
Sarcoma (1)
8940 N. Wood Sage Rd | Peoria, IL 61615-7822